The Multiphoton Microscopy Market in 2026 is experiencing growing research and translational interest in coherent Raman microscopy techniques including coherent anti-Stokes Raman scattering and stimulated Raman scattering microscopy that provide label-free chemical imaging of biological tissues through the vibrational spectroscopic contrast of molecular bonds, enabling visualization of lipids, proteins, nucleic acids, and water in living cells and tissues without fluorescent labeling that could perturb biological function or introduce phototoxicity. Coherent Raman scattering microscopy techniques exploit the coherent amplification of Raman vibrational signals through two synchronized pulsed laser beams tuned to specific Raman frequency differences, with CARS using the blue-shifted anti-Stokes emission at a frequency above the pump laser and SRS detecting the stimulated Raman gain or loss in the probe beam that is linearly proportional to the vibrational transition population, both providing orders of magnitude stronger signal than spontaneous Raman scattering that enables video-rate imaging at physiologically relevant sample temperatures without the photodamage of ultraviolet fluorescence excitation or the background issues of autofluorescence that limit single-photon fluorescence imaging in native tissue. The most chemically specific and biologically useful Raman contrast in biological imaging comes from lipid carbon-hydrogen stretching vibrations at approximately two thousand eight hundred fifty to two thousand nine hundred fifty wavenumbers that enable visualization of cellular lipid droplets, myelin sheaths, sebaceous gland lipids, and adipose tissue with high contrast against protein and aqueous backgrounds, creating applications in lipid metabolism research, neurological disease myelin imaging, and dermatological sebaceous gland characterization that are pursued at research and early translational imaging centers.

The translational application of coherent Raman microscopy in surgical pathology is generating research interest in label-free intraoperative tissue characterization, where CARS or SRS imaging of fresh unprocessed tissue biopsy samples or surgical margins could provide histopathological information comparable to hematoxylin-eosin stained frozen sections without the fifteen to thirty minute preparation time required for conventional intraoperative frozen section pathology. Research demonstrating that SRS microscopy can distinguish tumor from normal brain tissue, cancer from normal breast tissue, and adipose from fibrous tissue from fresh unprocessed specimens with accuracy approaching conventional histopathology is motivating clinical translation programs at major cancer centers that seek to develop coherent Raman microscopy as an intraoperative margin assessment tool that could reduce the positive margin rate and associated reoperation burden in cancer surgery. The development of miniaturized fiber-optic coherent Raman endoscopy probes that enable in vivo label-free tissue characterization through endoscopic access to internal organs without excision represents an ambitious frontier application of coherent Raman technology for gastrointestinal, pulmonary, and urological diagnostic endoscopy, with research prototypes demonstrating tissue-specific chemical contrast through flexible fiber bundle probes that bring the Raman imaging capability to internal tissue surfaces in animal models. As the imaging speed, chemical specificity, and tissue penetration depth of coherent Raman microscopy improve through ultrafast laser source development, dual-comb spectroscopy integration, and adaptive illumination techniques, the technology is expected to progressively advance from research instrumentation toward translational clinical applications in intraoperative diagnostics and in vivo tissue characterization.

Do you think coherent Raman microscopy will achieve sufficient imaging speed and instrument compactness to become a practical intraoperative cancer margin assessment tool within the next decade, replacing frozen section pathology for some surgical indications?

FAQ

• What is the physical difference between coherent anti-Stokes Raman scattering and stimulated Raman scattering microscopy and which technique provides superior contrast for biological imaging? CARS uses two synchronized laser beams where the frequency difference matches a molecular vibrational transition, generating coherent anti-Stokes emission at the blue-shifted frequency above the pump laser through a four-wave mixing process that produces strong blue-shifted signal detectable against negligible fluorescence background at this wavelength, but the CARS signal contains a non-resonant background from electronic contributions that creates a non-specific background reducing chemical contrast, while SRS measures the stimulated transfer of photons from the pump to the Stokes beam occurring only when the frequency difference matches a vibrational resonance, providing purely chemically specific signal without non-resonant background that makes SRS spectra directly comparable to spontaneous Raman spectra enabling straightforward chemical identification, making SRS generally preferred for quantitative chemical imaging despite its more technically demanding detection requiring lock-in amplification to extract small stimulated transfer signals from intense laser backgrounds.
• How does coherent Raman microscopy enable myelin imaging in neurological disease research and what has it revealed about demyelinating conditions? Coherent Raman microscopy provides exquisitely specific myelin contrast through the intense lipid carbon-hydrogen stretch signal from the densely packed lipid bilayers of myelin sheaths surrounding axons, enabling morphological assessment of myelin integrity, g-ratio measurement relating axon diameter to total fiber diameter, and visualization of myelin degradation and remyelination dynamics in experimental demyelinating disease models, with label-free imaging allowing longitudinal chronic imaging of the same axons across disease progression and treatment studies without the potential confounds of exogenous myelin labeling agents, revealing heterogeneous myelin degradation patterns, paranodal myelin abnormalities preceding frank demyelination, and incomplete remyelination with thin irregular myelin in multiple sclerosis animal models that provide mechanistic insights into remyelination failure.

#MultiphotonMicroscopy #CoherentRaman #SRS #CARS #LabelFreeImaging #TissuePathology